Ursodiol and Concussion - a phase IV clinical study of FDA data

Summary:

Concussion is reported as a side effect among people who take Ursodiol (ursodiol), especially for people who are female, 60+ old, also take Ocaliva, and have Cataplexy.

The phase IV clinical study analyzes which people have Concussion when taking Ursodiol. It is created by eHealthMe based on reports of 18,820 people who have side effects when taking Ursodiol from the FDA, and is updated regularly.

What is Ursodiol?

Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.

What is Concussion?

Concussion (short loss of normal brain function in response to a head injury) is found to be associated with 771 drugs and 780 conditions by eHealthMe. Check the latest studies of Concussion.

On Aug, 10, 2026

18,820 people reported to have side effects when taking Ursodiol.
Among them, 11 people (0.06%) have Concussion.

Among these 11 people:

What is the gender of people who have Concussion when taking Ursodiol? *

female: 100 %
male: 0.0 %

What is the age of people who have Concussion when taking Ursodiol? *

What are other drugs people take besides Ursodiol? *

Ocaliva: 7 people, 63.64%
Xyrem: 3 people, 27.27%
Neurontin: 3 people, 27.27%
Baclofen: 3 people, 27.27%
Clindamycin Hydrochloride: 3 people, 27.27%
Elestrin: 3 people, 27.27%
Fish Oil: 3 people, 27.27%
Lexapro: 3 people, 27.27%
Malarone: 3 people, 27.27%
Myrbetriq: 3 people, 27.27%

What are other side effects people have besides Concussion? *

Fall: 8 people, 72.73%
Craniocerebral Injury (injury to cranium and brain): 3 people, 27.27%
Pain: 3 people, 27.27%
Encephalopathy (functioning of the brain is affected by some agent or condition): 3 people, 27.27%
Visual Impairment: 3 people, 27.27%
Lyme Disease (a bacterial infection that is spread to humans by infected ticks): 3 people, 27.27%
Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function): 3 people, 27.27%
Neuropathy Peripheral (surface nerve damage): 3 people, 27.27%
Fatigue (feeling of tiredness): 3 people, 27.27%
Post-Traumatic Stress Disorder: 3 people, 27.27%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 27.27%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 27.27%
Drowsiness: 2 people, 18.18%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ursodiol and have Concussion?

- Check whether Concussion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ursodiol:

Ursodiol (19,061 reports)

Concussion treatments and more:

Concussion (9,904 reports)

Browse all side effects of Ursodiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Concussion:

Concussion (771 drugs)

Browse all the conditions that are associated with Concussion:

Concussion (780 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol (the active ingredients of Ursodiol) and Ursodiol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.